Mohit Bansal analyst WELLS FARGO

Currently, out of the existing stock ratings of Mohit Bansal - 147 which are a Buy (63.36%), 81 which are a Hold (34.91%), 4 which are a Sell (1.72%)

Mohit Bansal

Work Performance Price Targets & Ratings Chart

Analyst Mohit Bansal works at WELLS FARGO and is covering the Healthcare sector with 429 price targets and ratings displayed on 29 stocks. Previously, Mohit Bansal worked at CITI.

Mohit Bansal's average stock forecast success ratio is 59.8% with an average time for price targets to be met of 210.97 days.

Most recent stock forecast was given on KRTX, Karuna Therapeutics at 22-Aug-2023.

Wall Street Analyst Mohit Bansal

Analyst best performing recommendations are on KRTX (KARUNA THERAPEUTICS).
The best stock recommendation documented was for KRTX (KARUNA THERAPEUTICS) at 11/18/2019. The price target of $115 was fulfilled within 1 day with a profit of $19 (19.79%) receiving and performance score of 197.92.

Average potential price target upside

AGIO Agios Pharmaceuticals ALXN AMGN Amgen BIIB Biogen BMRN BioMarin Pharmaceutical CALA Calithera Biosciences CHRS Coherus BioSciences CTMX CytomX Therapeutics EPZM Epizyme FOLD Amicus Therapeutics GILD Gilead Sciences LLY Eli Lilly and Company MYOK MYOV Myovant Sciences Ltd PFE Pfizer RDUS Radius Health REGN Regeneron Pharmaceuticals VRTX Vertex Pharmaceuticals ABBV AbbVie BMY BristolMyers Squibb Company KRTX Karuna Therapeutics MRK Merck . SNSE STTK NBIX Neurocrine Biosciences BOLD CERE Cerevel Therapeutics Holdings HALO Halozyme Therapeutics ONCE

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

42

$17.46 (71.15%)

67

3 months 1 days ago

5/9 (55.56%)

$22.28 (52.87%)

241

Sell

32

$7.46 (30.40%)

16

10 months 11 days ago

4/6 (66.67%)

$-1.5 (-5.74%)

152

Buy

37

$12.46 (50.77%)

33

1 years 1 months 23 days ago

8/14 (57.14%)

$11.89 (32.81%)

54

Buy

96

$71.46 (291.20%)

96

1 years 6 months 25 days ago

0/6 (0%)

$53.67 (151.78%)

Buy

44

$19.46 (79.30%)

52

1 years 7 months 12 days ago

8/13 (61.54%)

$15.7 (35.07%)

175

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Mohit Bansal is most bullish on?

Potential upside of $147.44 has been obtained for REGN (REGENERON PHARMACEUTICALS)

Which stock is Mohit Bansal is most reserved on?

Potential downside of $7.11 has been obtained for BMY (BRISTOLMYERS SQUIBB COMPANY)

What Year was the first public recommendation made by Mohit Bansal?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart